Hostname: page-component-8448b6f56d-cfpbc Total loading time: 0 Render date: 2024-04-17T20:22:28.135Z Has data issue: false hasContentIssue false

Authors' reply

Published online by Cambridge University Press:  02 January 2018

Philippa A. Garety
Affiliation:
Department of Psychology, Institute of Psychiatry, King's College London, De Crespigny Park, London SE5 8AF. Email: philipa.garety@iop.kcl.ac.uk
David G. Fowler
Affiliation:
Department of Psychology and Psychiatry, School of Medicine, University of East Anglia, Norwich
Daniel Freeman
Affiliation:
Department of Psychology, Institute of Psychiatry, King's College London
Paul Bebbington
Affiliation:
Mental Health Sciences, University College London
Graham Dunn
Affiliation:
Health Medical Research Group, Community Based Medicine, University of Manchester
Elizabeth Kuipers
Affiliation:
Department of Psychology, Institute of Psychiatry, King's College London, UK
Rights & Permissions [Opens in a new window]

Abstract

Type
Columns
Copyright
Copyright © Royal College of Psychiatrists, 2008 

Marlowe notes that the primary outcome of our trial was relapse and comments that it is surprising, therefore, that it was not analysed in more detail. McKenna et al attempt to analyse the relapse data further. Neither Marlowe nor McKenna et al appear to understand the inferential problems raised by the lack of full or partial remission in a considerable proportion of the patients in this trial. The number with full or partial remission is itself an outcome of the trial (i.e. it is a post-randomisation measure). Those who have shown no recovery are excluded from the relapse data that Marlowe and McKenna et al present. In fact, twice as many people show no recovery in TAU as in CBT (18:9). The data reported by Marlowe and McKenna et al are therefore not a causal effect of randomisation (i.e. not an intention-to-treat effect). Because of this problem, we used months in full or partial remission as our primary indicator of outcome for which a formal intention-to-treat analysis is presented. This analysis and also a further examination of total days in hospital and number of admissions very clearly demonstrate that CBT, family intervention and TAU do not differ. We also reported fully on deaths and other adverse events and found no differences (the only completed suicide was in TAU). We are therefore not at all convinced by the suggestion that psychological intervention might be detrimental. Indeed, we infer on the basis of the results of this trial and of numerous meta-analyses (e.g. Pfammatter et al, Reference Pfammatter, Jungham and Brenner1 Pilling et al Reference Pilling, Bebbington, Kuipers, Garety, Geddes, Orbach and Morgan2 and Wykes et al Reference Wykes, Steel, Everitt and Tarrier3 ) that CBT and family intervention are beneficial for certain populations for a range of outcomes.

With respect to the point raised by Marlowe on the effects of having a carer on a psychological intervention, we are of course very aware of the Hogarty et al study, Reference Hogarty, Kornblith, Greenwald, DiBarry, Cooley, Ulrich, Carter and Flesher4,Reference Hogarty, Greenwald, Ulrich, Kornblith, DiBarry, Cooley, Carter and Flesher5 which we also discuss. It reported mixed findings. Our point here concerned the apparently beneficial effect of having a carer on CBT, which has not been examined before.

References

1 Pfammatter, M, Jungham, UM, Brenner, HD. Efficacy of psychological therapy in schizophrenia: conclusions from meta-analyses. Schizophr Bull 2006; 32 (suppl 1): s6480.CrossRefGoogle ScholarPubMed
2 Pilling, S, Bebbington, P, Kuipers, E, Garety, P, Geddes, J, Orbach, G, Morgan, C. Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychol Med 2002; 32: 763–82.CrossRefGoogle ScholarPubMed
3 Wykes, T, Steel, C, Everitt, B, Tarrier, N. Cognitive behaviour therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull 2008; 34: 523–37.Google Scholar
4 Hogarty, GE, Kornblith, SJ, Greenwald, P, DiBarry, AL, Cooley, S, Ulrich, RF, Carter, M, Flesher, S. Three years trials of personal therapy with schizophrenics living with or independent of family. I: Description of study and effects on relapse rates. Am J Psychiatry 1997; 154: 1504–13.Google Scholar
5 Hogarty, GE, Greenwald, P, Ulrich, RF, Kornblith, SJ, DiBarry, AL, Cooley, S, Carter, M, Flesher, S. Three years trials of personal therapy with schizophrenics living with or independent of family. II: Effects on adjustment of patients. Am J Psychiatry 1997; 154: 1514–24.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.